跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Indirin - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Indirin
Approved
STANDARD
Indirin
Sydenham Laboratories, Inc.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
1cede8e0c6e85801
Company
Sydenham Laboratories, Inc.
Type
Standard
Approval Details
Approval Id
1cede8e0c6e85801
Drug Approval Philippines Name
Indirin
Product Name
Indirin
Registration Number
DR-XY46106
Brand Name
Indirin
Generic Name
Propranolol Hydrochloride
Dosage Form
Film-Coated Tablet
Dosage Strength
40 mg
Manufacturer
Sydenham Laboratories, Inc.
Trader
Medchoice Endocrine Group, Inc.
Issuance Date
24 June 2022
Expiry Date
18 October 2027
Pharmacologic Category
Antihypertensive/Anti-Angina (Beta-Adrenoreceptor Blocker)
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
1cede8e0c6e85801
Type
Standard
Back to Philippines FDA Approvals